Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solana Co Director's Dealing 2021

Jul 8, 2021

32724_dirs_2021-07-08_662fa7c6-8282-42f7-90e0-2f71dc963a51.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2021-07-06

Reporting Person: Favit-Van Pelt Antonella R. (Chief Medical Officer)